MLICM
ENFN

Metropolitan Life Insurance Company (MetLife)’s Enfusion, Inc. ENFN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,295
Closed -$21.2K – 2200
2024
Q1 		$21.2K Hold
2,295
– – ﹤0.01% 1829
2023
Q4 		$22.3K Hold
2,295
– – ﹤0.01% 1873
2023
Q3 		$20.6K Buy
2,295
+589
+35% +$5.59K ﹤0.01% 1887
2023
Q2 		$19.1K Hold
1,706
– – ﹤0.01% 1958
2023
Q1 		$17.9K Hold
1,706
– – ﹤0.01% 1939
2022
Q4 		$16.5K Hold
1,706
– – ﹤0.01% 2103
2022
Q3 		$21.1K Hold
1,706
– – ﹤0.01% 2005
2022
Q2 		$17.4K Hold
1,706
– – ﹤0.01% 2108
2022
Q1 		$21.7K Sell
1,706
-5,065
-75% -$77.4K ﹤0.01% 2052
2021
Q4 		$142K Buy
+6,771
New +$137K ﹤0.01% 2253

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
NCM
Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ENFN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Enfusion, Inc. (ENFN) in Q2 2024, closing a stake of 2,295 shares — an estimated $21.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ENFN in Q4 2021 and held it in 10 quarters. The position peaked at $142K in Q4 2021. 101 funds tracked by Wall St. Rank hold ENFN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Enfusion, Inc. position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,295 Enfusion, Inc. shares in Q2 2024, an estimated $21.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Enfusion, Inc. in Q4 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Enfusion, Inc. position peaked at $142K in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.